London Institute of Cancer Research: New Targeted Drugs Can Be Effective for Relapsed Myeloma That Has Stopped Responding to Recommended Secondary Treatment, Study Shows
September 16, 2026
September 16, 2026
LONDON, England, Sept. 16 -- The Institute of Cancer Research issued the following news:
* * *
New targeted drugs can be effective for relapsed myeloma that has stopped responding to the recommended secondary treatment, study shows
16/09/26
Scientists have provided important evidence that a drug commonly used to treat a type of blood cancer does not appear to reduce patients' chances of benefiting from later therapies targeting the same p . . .
* * *
New targeted drugs can be effective for relapsed myeloma that has stopped responding to the recommended secondary treatment, study shows
16/09/26
Scientists have provided important evidence that a drug commonly used to treat a type of blood cancer does not appear to reduce patients' chances of benefiting from later therapies targeting the same p . . .